Characterization of a Bacteroides species from human intestine that degrades glycosaminoglycans

被引:62
作者
Ahn, MY
Shin, KH
Kim, DH
Jung, EA
Toida, T
Linhardt, RJ
Kim, YS [1 ]
机构
[1] Seoul Natl Univ, Inst Nat Prod Res, Seoul 110460, South Korea
[2] Kyunghee Univ, Coll Pharm, Seoul 130701, South Korea
[3] Chiba Univ, Fac Pharmaceut Sci, Chiba 263, Japan
[4] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52240 USA
[5] Univ Iowa, Dept Chem & Biochem Engn, Iowa City, IA 52240 USA
关键词
Bacteroides stercoris; glycosaminoglycan; nuclear magnetic resonance spectroscopy; polysaccharide lyase; heparinase; chondroitinase;
D O I
10.1139/cjm-44-5-423
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polysaccharide lyases that can degrade glycosaminoglycans (GAGs) were identified in an anaerobic strain living in the human intestine. The strain was isolated from the stool of a healthy male and identified as Bacteroides sp. strain HJ-15. A detailed taxonomical study indicated the species is a strain of Bacteroides stercoris. The isolate was cultured and the polysaccharide lyase activity was partially purified. This enzyme preparation could act on GAGs containing either glucosamine or galactosamine suggesting the presence of both heparinases and chondroitinases. Various GAGs were incubated with the partially purified enzyme and the products formed were analyzed by strong anion-exchange high performance liquid chromatography and proton nuclear magnetic resonance spectroscopy. These studies demonstrated the presence of at least two types of polysaccharide lyases: heparin lyase and chondroitin sulfate lyase. The eliminative mechanism of these lyase enzymes was confirmed through the isolation of unsaturated disaccharide products. The heparin lyase acted on both heparin and acharan sulfate, a GAG recently isolated from Achatina fulica. The Bacteroides chondroitin lyase, acted on chondroitin sulfates A, B (dermatan sulfate), and C, resembling chondroitin lyase ABC. The presence of a GAG-degrading organism in human intestine may pose problems for the effective oral administration of GAG drugs.
引用
收藏
页码:423 / 429
页数:7
相关论文
共 44 条
  • [1] Bame KJ, 1997, J BIOL CHEM, V272, P2245
  • [2] Bellamy R.W., 1992, United States Patent and Trademark, Patent No. 5145778
  • [3] BOHMER LH, 1990, J BIOL CHEM, V265, P13609
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate
    Chen, YP
    Maguire, T
    Hileman, RE
    Fromm, JR
    Esko, JD
    Linhardt, RJ
    Marks, RM
    [J]. NATURE MEDICINE, 1997, 3 (08) : 866 - 871
  • [6] SHORT PREREDUCED ANAEROBICALLY STERILIZED (PRAS) BIOCHEMICAL SCHEME FOR IDENTIFICATION OF CLINICAL ISOLATES OF BILE-RESISTANT BACTEROIDES SPECIES
    CITRON, DM
    BARON, EJ
    FINEGOLD, SM
    GOLDSTEIN, EJC
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (10) : 2220 - 2223
  • [7] Orally ingested heparin is absorbed in humans
    Engelberg, H
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1995, 1 (04) : 283 - 285
  • [8] ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS
    ERNST, S
    LANGER, R
    COONEY, CL
    SASISEKHARAN, R
    [J]. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (05) : 387 - 444
  • [9] HEPARINASE PRODUCTION BY FLAVOBACTERIUM-HEPARINUM
    GALLIHER, PM
    COONEY, CL
    LANGER, R
    LINHARDT, RJ
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1981, 41 (02) : 360 - 365
  • [10] REGULATION OF HEPARINASE SYNTHESIS IN FLAVOBACTERIUM-HEPARINUM
    GALLIHER, PM
    LINHARDT, RJ
    CONWAY, LJ
    LANGER, R
    COONEY, CL
    [J]. EUROPEAN JOURNAL OF APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 1982, 15 (04): : 252 - 257